logo

Slide Shows

Share
Events

Biotech Stocks Facing FDA Decision In June 2022 As another month comes to a close, it’s time to take a look back at some of the healthcare sector news that made headlines in May and look ahead to what’s in store on the regulatory front in June.

Biotech Stocks Facing FDA Decision In March 2022 As another month comes to an end, it’s time to take a look back at some of the regulatory news that made headlines in February and look ahead to what the month of March has in store.

Biotech Stocks Facing FDA Decision In January 2022 As another month comes to an end, we take a look back at some of the regulatory news that dominated the headlines and look ahead to what’s in store for January.

Biotech Stocks Facing FDA Decision In December 2021 Just when everyone thought that the worst of the Covid-19 pandemic may be behind us, the emergence of Omicron, a new coronavirus variant, is causing global concern. Detected first in South Africa earlier this month, Omicron cases have now been reported in at least 15 countries.